AmeriServ Financial (ASRV) shares surged 54% pre-bell Monday on lower-than-average trading volume, following a 3.4% increase on Friday.
Portage Biotech (PRTG) shares advanced nearly 55% after the company said results from a clinical study showed agent activity for its mesothelioma, a cancer drug that was superior to treatment with single agent anti-PD1 antibody.
UroGen Pharma (URGN) stock was up 6%, a day after the company said long-term data from a follow-up analysis of a phase 3 trial of its urothelial cancer therapy showed treatment response duration of nearly four years.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.